TEVARD BIOSCIENCES
Tevard Biosciences provides treatments and durable cures for many types of critical and rare genetic diseases based on biotechnology.
TEVARD BIOSCIENCES
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.tevard.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
CrUX Top 50m CrUX Dataset
Similar Organizations
Symmetry Therapeutics, Inc.
Creating the world’s most robust mitochondrial carrier drug platform to treat common and rare metabolic diseases.
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2023-11-13 | Tevard Biosciences appoints Dr. Gregory Robinson as Chief Scientific Officer |
Official Site Inspections
http://www.tevard.com Semrush global rank: 8.35 M Semrush visits lastest month: 559
- Host name: server.meiler.com
- IP address: 107.190.141.2
- Location: Orlando United States
- Latitude: 28.5807
- Longitude: -81.1893
- Metro Code: 534
- Timezone: America/New_York
- Postal: 32826
More informations about "Tevard Biosciences"
Tevard Biosciences to Move Corporate Headquarters to Lilly …
August 13, 2024, Cambridge, MA — Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today …See details»
Tevard CEO Awarded Henri Termeer Fellowship
Apr 26, 2022 Tevard CEO Awarded Henri Termeer Fellowship April 26, 2022 at 2:42 am. The Termeer Foundation, a nonprofit organization focused on connecting life science innovators …See details»
Tevard Biosciences - Crunchbase Company Profile & Funding
Organization. Tevard Biosciences . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Tevard Biosciences provides treatments and …See details»
Tevard Biosciences to Move Corporate Headquarters …
Aug 13, 2024 Tevard Biosciences is pioneering tRNA-based and other mRNA-modulating therapies to cure a broad range of genetic diseases. The privately held biotechnology company was founded by renowned ...See details»
Tevard Biosciences to Move Corporate Headquarters to Lilly …
Aug 13, 2024 Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today announced that it will …See details»
Tevard Biosciences - VentureRadar
" Tevard Biosciences is developing lifelong cures for patients with rare genetic diseases. We are pioneering tRNA-based gene therapies to treat severe genetic diseases not amenable to …See details»
An Interview With Tevard Biosciences President and CEO Daniel …
Aug 22, 2023 Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Daniel Fischer, president and CEO of Tevard Biosciences. Fischer and his business partner, Warren …See details»
Tevard Biosciences appoints Dr. Gregory Robinson as Chief …
Tevard Biosciences is pioneering tRNA-based and other mRNA-modulating therapies to cure a broad range of genetic diseases. The privately held biotechnology company was founded by …See details»
Tevard Biosciences - Contacts, Employees, Board Members
Tevard Biosciences has 3 current employee profiles, including Co-Founder & Chairman Warren Lammert. Warren Lammert Co-Founder & Chairman Daniel Fischer President & Chief …See details»
Tevard - Industry Veteran and RNA Therapeutics Expert, John …
June 24, 2024 --- Cambridge, MA --- Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today …See details»
Tevard Biosciences appoints Dr. Gregory Robinson as Chief …
Nov 13, 2023 Tevard Biosciences, Inc., the pioneer of tRNA-based therapies and other mRNA-modulating treatments for genetic diseases, announced today that it has appointed Dr. …See details»
Tevard’s tRNA therapies gain ground for genetic epilepsies
Aug 15, 2024 With a move into Lilly Gateway Labs in Boston’s Seaport District, privately held Tevard Biosciences Inc. is ramping up development of its transfer RNA (tRNA)-based …See details»
Tevard Biosciences Pursues Gene Therapy to Treat Dravet, Possibly …
Aug 22, 2023 The entrance to Tevard Biosciences, a small biotech company in Cambridge, Massachusetts, that hopes to develop a treatment for Dravet syndrome. (Photo by Larry …See details»
Tevard Biosciences licenses mRNA Amplifier technology from …
Mar 31, 2022 Tevard is exploring the use of its novel Suppressor tRNA, Enhancer tRNA, and mRNA Amplifier platforms in neurological disorders, heart disease, and muscular dystrophies; …See details»
Tevard Biosciences and Zogenix Announce Collaboration to …
Dec 3, 2020 Tevard Biosciences Investors and Media Karen L. Bergman for Tevard +1 (650) 575-1509 [email protected]. Zogenix Melinda Baker Senior Director, Corporate …See details»
Tevard Biosciences announces collaboration with Vertex to …
Feb 28, 2023 Tevard Biosciences is pioneering tRNA-based therapies to cure a broad range of genetic diseases. The privately held biotechnology company was founded by MIT Professor …See details»
News – Tevard Biosciences – Lifelong cures for patients with rare ...
Tevard Biosciences – Lifelong cures for patients with rare genetic diseases - Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with …See details»
Tevard Biosciences and Vertex partner for DLD tRNA therapies
Mar 1, 2023 Tevard CEO and co-founder Daniel Fischer said: “Given Vertex’s proven track record of developing novel therapies to treat serious disease, we’re thrilled to partner with …See details»
Jeffrey Walsh – Tevard Biosciences – Lifelong cures for patients …
Mar 4, 2020 Jeff Walsh is strategic advisor and former Chief Financial and Strategy Officer at Bluebird Bio which he joined in 2011. He served in a variety of roles during bluebird’s growth …See details»